This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: Reinhold Lohr: Innovator in Pharmaceutical Formulations and Fish Parasite Combat
Introduction
Reinhold Lohr is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that address various medical needs. With a total of 2 patents, his work has garnered attention in both academic and industrial circles.
Latest Patents
Lohr's latest patents include innovative formulations for orally administrable quinolone- or naphthyridonecarboxylic acids. This invention focuses on the preparation of these formulations by mixing the active ingredients with embonic acid and other excipients, enhancing their effectiveness and usability. Another significant patent addresses the use of agonists and antagonists of nicotinergic acetylcholine receptors in insects to combat fish parasites, showcasing his versatility in tackling diverse challenges in the pharmaceutical industry.
Career Highlights
Reinhold Lohr is currently associated with Bayer Aktiengesellschaft, a leading global enterprise in the pharmaceutical and life sciences sector. His role at Bayer has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Lohr has worked alongside esteemed colleagues such as Oliver Vetter and Matthias Kuhn. Their combined expertise has fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Reinhold Lohr's contributions to pharmaceutical formulations and pest control highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the industry and inspire future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
